Dogwood Therapeutics (DWTX)
NASDAQ:DWTX
US Market
Holding DWTX?
Track your performance easily

Dogwood Therapeutics (DWTX) Income Statement

117 Followers

Dogwood Therapeutics Income Statement

Last quarter (Q2 2024), Dogwood Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Dogwood Therapeutics's net income was $-1.05M. See Dogwood Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
----$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 4.80M$ 5.45M$ 12.32M$ 15.64M$ 10.01M$ 2.18M
Operating Income
$ -4.80M$ -5.45M$ -12.32M$ -15.64M$ -10.01M$ -2.18M
Net Non Operating Interest Income Expense
$ 116.92K$ 150.90K$ 67.47K$ 5.67K$ -384.22K$ -295.13K
Other Income Expense
---$ 325.00K$ 43.22K-
Pretax Income
$ -4.68M$ -5.30M$ -12.25M$ -15.96M$ -10.35M$ -2.47M
Tax Provision
----$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -4.68M$ -5.30M$ -12.25M$ -15.96M$ -10.35M$ -2.47M
Basic EPS
$ -0.24$ -0.28$ -1.11$ -1.92$ -2.10$ -0.51
Diluted EPS
$ -0.24$ -0.28$ -1.11$ -1.92$ -2.10$ -0.51
Basic Average Shares
$ 80.52M$ 18.78M$ 11.07M$ 8.33M$ 4.93M$ 4.83M
Diluted Average Shares
$ 80.52M$ 18.78M$ 11.07M$ 8.33M$ 4.93M$ 4.83M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 4.80M$ 5.45M$ 12.32M$ 15.64M$ 10.01M$ 2.18M
Net Income From Continuing And Discontinued Operation
$ -4.68M$ -5.30M$ -12.25M$ -15.96M$ -10.35M$ -2.47M
Normalized Income
$ -2.89M$ -4.18M--$ -10.35M$ -2.47M
Interest Expense
----$ 384.22K$ 295.13K
EBIT
$ -4.78M$ -5.45M$ -12.32M$ -15.97M$ -10.01M$ -2.18M
EBITDA
$ -4.78M$ -5.45M$ -12.32M$ -15.97M$ -10.01M$ -2.18M
Currency in USD

Dogwood Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis